| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 20,935 | 18,056 | 17,311 | 17,232 | | Cost of Revenue | 6,339 | 6,006 | 6,567 | 6,189 | | | Gross Profit | 14,596 | 12,050 | 10,744 | 11,044 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,828 | 7,770 | 7,496 | 7,246 | | Non Recurring |
-
| (222) | 222 |
-
| | Others | 809 | 746 | 870 | 731 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,960 | 3,756 | 2,157 | 3,067 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (121) | 2 | 6 | (29) | | Earnings Before Interest And Taxes | 3,765 | 3,684 | 2,089 | 2,965 | | Interest Expense | 812 | 803 | 833 | 874 | | Income Before Tax | 2,954 | 2,881 | 1,256 | 2,091 | | Income Tax Expense | 1,064 | 1,038 | 465 | 648 | | Minority Interest | (74) | (74) | (74) | (74) | | | | Net Income From Continuing Ops | 1,889 | 1,843 | 791 | 1,443 | | | Non-recurring Events | | Discontinued Operations | (105) | (1,003) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,784 | 839 | 791 | 1,443 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,784 | $839 | $791 | $1,443 |
|
0.17% Nasdaq 
Income Statement
